[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Yuling Luo<\/i><\/u><\/presenter>. Alamar Biosciences, Fremont, CA","CSlideId":"","ControlKey":"70515132-fa2a-4bbe-a53c-0d7a416b12b4","ControlNumber":"11494","DisclosureBlock":"","End":"4\/9\/2024 1:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10150","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"YULING LUO","PresenterKey":"2c7266c3-eee8-45f7-905f-d9626cdfba0a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Advances in high sensitivity protein detection from biofluids and the potential in early diagnosis and therapeutic monitoring","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024 12:30PM","SessionId":"585","SessionOnDemand":"False","SessionTitle":"Advances in High Sensitivity Protein Detection from Biofluids and the Potential in Early Diagnosis and Therapeutic Monitoring","ShowChatLink":"false","Start":"4\/9\/2024 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Advances in high sensitivity protein detection from biofluids and the potential in early diagnosis and therapeutic monitoring","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Xiao-Jun Ma<\/i><\/u><\/presenter>. Alamar Biosciences, Fremont, CA","CSlideId":"","ControlKey":"b3a16ac0-2a70-4712-851f-b1effe938edb","ControlNumber":"12538","DisclosureBlock":"","End":"4\/9\/2024 1:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"12282","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"XIAO-JUN MA","PresenterKey":"81f44d40-1c24-4c39-8422-e71cbffd5377","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discovery of novel biomarkers associated with CRS and ICANS after CAR-T therapy using NULISAseq&#8482; Inflammation panel 250","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024 12:30PM","SessionId":"585","SessionOnDemand":"False","SessionTitle":"Advances in High Sensitivity Protein Detection from Biofluids and the Potential in Early Diagnosis and Therapeutic Monitoring","ShowChatLink":"false","Start":"4\/9\/2024 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discovery of novel biomarkers associated with CRS and ICANS after CAR-T therapy using NULISAseq&#8482; Inflammation panel 250","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Yuehan Feng<\/i><\/u><\/presenter>. Biognosys AG, Schlieren, Switzerland","CSlideId":"","ControlKey":"a2b27f24-5bb2-4863-be7a-311914a9088f","ControlNumber":"12531","DisclosureBlock":"","End":"4\/9\/2024 1:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"12275","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Yuehan Feng, PhD","PresenterKey":"7307bad2-eacb-448b-9ce8-96a5ea8dcbd1","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Predictive biomarker discovery by multiomic analysis of baseline plasma samples from a Phase II oncology clinical trial","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024 12:30PM","SessionId":"585","SessionOnDemand":"False","SessionTitle":"Advances in High Sensitivity Protein Detection from Biofluids and the Potential in Early Diagnosis and Therapeutic Monitoring","ShowChatLink":"false","Start":"4\/9\/2024 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Predictive biomarker discovery by multiomic analysis of baseline plasma samples from a Phase II oncology clinical trial","Topics":null,"cSlideId":""}]